G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,409 | +8.3% | 105,385 | +136.3% | 0.01% | -23.1% |
| Q4 2022 | $242,194 | -50.9% | 44,603 | +12.9% | 0.01% | -31.6% |
| Q3 2022 | $493,000 | +142.9% | 39,500 | -3.8% | 0.02% | +111.1% |
| Q2 2022 | $203,000 | +2.5% | 41,054 | +111.6% | 0.01% | -25.0% |
| Q4 2021 | $198,000 | -73.4% | 19,400 | -42.8% | 0.01% | -83.3% |
| Q2 2021 | $744,000 | +107.2% | 33,902 | +8.9% | 0.07% | 0.0% |
| Q3 2020 | $359,000 | – | 31,124 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |